Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020

SELL
$9.57 - $21.32 $37,323 - $83,148
-3,900 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$12.21 - $16.99 $47,619 - $66,261
3,900 New
3,900 $57,000
Q1 2020

May 12, 2020

SELL
$9.03 - $19.72 $93,912 - $205,088
-10,400 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$13.01 - $17.15 $135,304 - $178,359
10,400 New
10,400 $147,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $740M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.